Anda belum login :: 23 Nov 2024 08:00 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series
Oleh:
Trigo, Jose M.
;
Soliman, Alexandra
;
Staios, Gregory
;
Quilty, Lena
;
Fischer, Benedikt
;
George, Tony P.
;
Rehm, Jurgen
;
Selby, Peter
;
Barnes, Allan J.
;
Huestis, Marilyn A.
;
Le Foll, Bernard
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Journal of Addiction Medicine vol. 10 no. 04 (Jul. 2016)
,
page 274-279.
Topik:
Abstinence
;
Cannabidiol
;
Cannabis
;
Marijuana
;
THC
;
Withdrawal
Ketersediaan
Perpustakaan FK
Nomor Panggil:
J06.K
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Objectives: Cannabis is the most commonly used illicit drug; a substantial minority of users develop dependence. The current lack of pharmacological treatments for cannabis dependence warrants the use of novel approaches and further investigation of promising pharmacotherapy. In this case series, we assessed the use of self-titrated dosages of Sativex (1:1, ?9-tetrahydrocannabinol [THC]/cannabidiol [CBD] combination) and motivational enhancement therapy and cognitive behavioral therapy (MET/CBT) for the treatment of cannabis dependence among 5 treatment-seeking community-recruited cannabis-dependent subjects. Methods: Participants underwent a 3-month open-label self-titration phase with Sativex (up to 113.4 of THC/105?mg of CBD) and weekly MET/CBT, with a 3-month follow-up. Results: Sativex was well-tolerated by all participants (average dosage 77.5?THC/71.7?mg CBD). The combination of Sativex and MET/CBT reduced the amount of cannabis use and progressively reduced craving and withdrawal scores. THC/CBD metabolite concentration indicated reduced cannabis use and compliance with medication. Conclusions: In summary, this pilot study found that with Sativex in combination with MET/CBT reduced cannabis use while preventing increases in craving and withdrawal in the 4 participants completing the study. Further systematic exploration of Sativex as a pharmacological treatment option for cannabis dependence should be performed.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)